The Medacta Quadra-P Anteverted Study

Active, not recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

July 30, 2021

Primary Completion Date

July 31, 2032

Study Completion Date

July 31, 2032

Conditions
ArthrosisTraumatic ArthritisRheumatoid PolyarthritisCongenital Hip DysplasiaAvascular Necrosis of the Femoral Head
Interventions
DEVICE

Quadra P anteverted

"* Assess clinical performance by Harris Hip score collected during preoperative and postoperative visits at 3 months, 1, 2, 5, 7 and 10 years.~* Assess radiological performance by standard radiographic examination performed before surgery, after surgery before discharge and during postoperative visits at 3 months, 1, 2, 5, 7 and 10 years.~* Assessing the patient's perception of the prosthetic joint by means of FJS questionnaire collected during the preoperative visit and postoperative visits at 3 months and at 1, 2, 5, 7 and 10 years after surgery.~* Assessment of functional recovery by gait analysis study~* Collect the rate of complications throughout the course of the study"

Trial Locations (1)

Unknown

Istituto Ortopedico Franco Scalabrino, Messina

Sponsors
All Listed Sponsors
lead

Medacta International SA

INDUSTRY